Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001422848-25-000080
Filing Date
2025-05-13
Accepted
2025-05-13 11:32:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5548
  Complete submission text file 0001422848-25-000080.txt   7224
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Subject) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-42126 | Film No.: 25938162
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 333 SOUTH HOPE STREET 55TH FL LOS ANGELES CA 90071
Business Address 333 SOUTH HOPE STREET 55TH FL LOS ANGELES CA 90071 213-486-9200
Capital Research Global Investors (Filed by) CIK: 0001422848 (see all company filings)

EIN.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G